Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

Fluorescence-guided surgery has become a new standard of care for certain types of tumor resection. It involves a patient ingesting a substance prior to surgery that will metabolize and fluoresce ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

"This IND clearance is a major milestone for Trace and validates more than a decade of scientific work focused on making nerves visible to surgeons," said Connor Barth, Ph.D., Co-Founder and CEO of ...

A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...

Successful surgery for head and neck squamous cell carcinoma (HNSCC) relies upon complete tumor removal and safe preservation of the fragile nerves in the vicinity. Both are challenging. Fluorescence ...

Boston-based Mass General Cancer Center used fluorescent agent technology during breast cancer surgery to remove residual tumor cells and possibly prevent the need for secondary surgery. The study, ...

Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection ...

Light-guided cancer surgery has been in development for some time with varying degrees of success, from light therapy to glow-in-the-dark tumors and the development of compounds that can illuminate ...

MADISON, Wis.--(BUSINESS WIRE)--OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to ...